Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02633371 · ClinicalTrials.gov registry record · NA
A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02633371 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 10 participants.
The verdict
NCT02633371, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a single-center, prospective, open-label, outpatient pilot study evaluating the efficacy and tolerability of oxybutynin gel for axillary hyperhidrosis.
Interventions
- DRUG Oxybutynin 3% gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02633371
The ClinicalTrials.gov registry entry for NCT02633371 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxybutynin 3% gel is the first listed.
NCT02633371 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02633371 about?
NCT02633371 is a clinical study titled "A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults". This is a single-center, prospective, open-label, outpatient pilot study evaluating the efficacy and tolerability of oxybutynin gel for axillary hyperhidrosis.
What is the current status of trial NCT02633371?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-02. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02633371?
The interventions under investigation include: Oxybutynin 3% gel (DRUG).
Who is sponsoring clinical trial NCT02633371?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.